These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2051 related items for PubMed ID: 26003072

  • 1. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K, Sands D.
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [Abstract] [Full Text] [Related]

  • 2. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    Chinese Experts Cystic Fibrosis Consensus Committee, Chinese Alliance for Rare Lung Diseases, Chinese Alliance for Rare Diseases, Bronchiectasis-China.
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr 12; 46(4):352-372. PubMed ID: 36990700
    [Abstract] [Full Text] [Related]

  • 3. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis.
    Kraemer R, Deloséa N, Ballinari P, Gallati S, Crameri R.
    Am J Respir Crit Care Med; 2006 Dec 01; 174(11):1211-20. PubMed ID: 16959918
    [Abstract] [Full Text] [Related]

  • 4. Aspergillus/allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: a diagnostically challenging entity.
    Chotirmall SH, Branagan P, Gunaratnam C, McElvaney NG.
    Respir Care; 2008 Aug 01; 53(8):1035-41. PubMed ID: 18655741
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis.
    Jubin V, Ranque S, Stremler Le Bel N, Sarles J, Dubus JC.
    Pediatr Pulmonol; 2010 Aug 01; 45(8):764-71. PubMed ID: 20597074
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.
    Skov M, McKay K, Koch C, Cooper PJ.
    Respir Med; 2005 Jul 01; 99(7):887-93. PubMed ID: 15939251
    [Abstract] [Full Text] [Related]

  • 7. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.
    Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J, Strandvik B, McKenzie SG.
    Eur Respir J; 2000 Sep 01; 16(3):464-71. PubMed ID: 11028661
    [Abstract] [Full Text] [Related]

  • 8. Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function?
    de Vrankrijker AM, van der Ent CK, van Berkhout FT, Stellato RK, Willems RJ, Bonten MJ, Wolfs TF.
    Clin Microbiol Infect; 2011 Sep 01; 17(9):1381-6. PubMed ID: 21087348
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis.
    Ritz N, Ammann RA, Casaulta Aebischer C, Schoeni-Affolter F, Schoeni MH.
    Eur J Pediatr; 2005 Sep 01; 164(9):577-82. PubMed ID: 15926067
    [Abstract] [Full Text] [Related]

  • 10. Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
    Perisson C, Destruys L, Grenet D, Bassinet L, Derelle J, Sermet-Gaudelus I, Thumerelle C, Prevotat A, Rosner V, Clement A, Corvol H.
    Respir Med; 2017 Dec 01; 133():12-15. PubMed ID: 29173443
    [Abstract] [Full Text] [Related]

  • 11. Aspergillus bronchitis in cystic fibrosis.
    Shoseyov D, Brownlee KG, Conway SP, Kerem E.
    Chest; 2006 Jul 01; 130(1):222-6. PubMed ID: 16840406
    [Abstract] [Full Text] [Related]

  • 12. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
    Reece E, Segurado R, Jackson A, McClean S, Renwick J, Greally P.
    BMC Pulm Med; 2017 Apr 21; 17(1):70. PubMed ID: 28431569
    [Abstract] [Full Text] [Related]

  • 13. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab).
    Kanu A, Patel K.
    Pediatr Pulmonol; 2008 Dec 21; 43(12):1249-51. PubMed ID: 19009619
    [Abstract] [Full Text] [Related]

  • 14. Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
    De Baets F, De Keyzer L, Van Daele S, Schelstraete P, Van Biervliet S, Van Braeckel E, Thomas M, Wanyama SS.
    Pediatr Allergy Immunol; 2018 Nov 21; 29(7):726-731. PubMed ID: 29981532
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and risk factors for allergic bronchopulmonary aspergillosis in Indian children with cystic fibrosis.
    Sharma VK, Raj D, Xess I, Lodha R, Kabra SK.
    Indian Pediatr; 2014 Apr 21; 51(4):295-7. PubMed ID: 24825267
    [Abstract] [Full Text] [Related]

  • 16. Successful control of exacerbation of Allergic Bronchopulmonary Aspergillosis due to Aspergillus terreus in a cystic fibrosis patient with short-term adjunctive therapy with voriconazole: A case report.
    Hassanzad M, Mortezaee V, Bongomin F, Poorabdollah M, Sharifynia S, Maleki M, Hedayati N, Velayati AA, Hedayati MT.
    J Mycol Med; 2019 Jun 21; 29(2):189-192. PubMed ID: 30782501
    [Abstract] [Full Text] [Related]

  • 17. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole.
    Nepomuceno IB, Esrig S, Moss RB.
    Chest; 1999 Feb 21; 115(2):364-70. PubMed ID: 10027433
    [Abstract] [Full Text] [Related]

  • 18. Diverse clinical characteristics of Aspergillus growth in patients with cystic fibrosis.
    Emiralioğlu N, Doğru D, Doğan Ö, Gülmez D, Akdağlı SA, Polat SE, Tuğcu G, Hızal MG, Yalçın E, Özçelik U, Şener B, Kiper N.
    Turk J Pediatr; 2020 Feb 21; 62(4):560-568. PubMed ID: 32779408
    [Abstract] [Full Text] [Related]

  • 19. Voriconazole therapy in children with cystic fibrosis.
    Hilliard T, Edwards S, Buchdahl R, Francis J, Rosenthal M, Balfour-Lynn I, Bush A, Davies J.
    J Cyst Fibros; 2005 Dec 21; 4(4):215-20. PubMed ID: 16243008
    [Abstract] [Full Text] [Related]

  • 20. Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients.
    Fillaux J, Brémont F, Murris M, Cassaing S, Rittié JL, Tétu L, Segonds C, Abbal M, Bieth E, Berry A, Pipy B, Magnaval JF.
    Scand J Infect Dis; 2012 Nov 21; 44(11):842-7. PubMed ID: 22831545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 103.